COVID-19 vaccines have been around for half a year, what have we learned so far?

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: John Letzing, Digital Editor, Strategic Intelligence, World Economic Forum


  • Signs are so far encouraging in terms protection, safety, and saving lives.
  • More than 2 billion doses have been administered globally.
  • However, many people may not receive a single dose for at least another year.

One thing we know for sure: they don’t make you magnetic.

Those fortunate enough to receive the first available doses of COVID-19 vaccines have been serving as test subjects. Roughly half a year into this global experiment, what have we learned so far?

A pair of studies published last month suggested that vaccination can indeed provide a plausible path out of the pandemic, and by early June 2 billion doses had been administered worldwide since the first went to a woman in the UK the previous December.

COVID-19 vaccines had saved nearly an estimated 12,000 lives in England alone by last month, China has been vaccinating a population the size of Romania every day, and San Francisco, where nearly 70% of residents had been fully vaccinated as of early this month, is the first US city on the verge of herd immunity.

Globally, daily confirmed cases and deaths have been trending downward since April. So far, it’s safe to say, vaccines seem to be working well.

One real-world study published in March of people in Denmark prioritized for the Pfizer-BioNTech vaccine found it was 90% effective among healthcare workers, and 64% effective among residents of long-term care facilities with a median age of 84.

However, troubling variants like “Delta” in India, the UK, and the US have raised questions about their potential resilience to vaccines. A study published in the UK last month found that two doses of the Pfizer-BioNTech vaccine were 88% effective against symptomatic disease from Delta, though epidemiologists have warned that variants could ultimately render current vaccines ineffective in a year or less.

Potential side effects have been another concern. Rare occurrences of a blood-clotting syndrome have been linked to the Oxford-AstraZeneca and Johnson & Johnson vaccines, but experts say the benefits still outweigh the risks.

A fact overshadowing any good news about vaccines is that much of the world hasn’t yet been able to receive any doses at all. One analysis suggested that more than 85 countries, mostly in Africa, won’t have widespread COVID-19 vaccine access before 2023.

Below is a visualization of COVID-19 vaccination doses administered per 100 people between January and May of this year – each country turns white as data becomes available, then progressively darker blue as the number of administered doses increases.

US date format.
COVID-19 vaccination doses administered per 100 people between January and May of this year. Image: World Economic Forum

According to the Centers for Disease Control in the US, fully vaccinated people should be able to resume activities without masks (except where mandated), and travel without testing or quarantining. Still, experts caution against gatherings of multiple households without precautions if some people there are unvaccinated.

A study published in April in the UK found that receiving a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines notably reduced the odds of infecting other household members, and another published last month found that the viral load was significantly diminished for people in Israel infected a couple of weeks past their first dose of Pfizer-BioNTech – making them less infectious to others.

Yet another study published by the US CDC last month showed that two doses of the Pfizer-BioNTech and Moderna vaccines reduced the risk of healthcare workers getting sick with COVID-19 by 94%.

Researchers are still gathering what scant evidence has accumulated so far on how long protection lasts after vaccination. The role of booster shots may start to become clearer in September, when results from a study in England providing boosters to people at least 10 weeks past their second vaccine dose are anticipated.

Unfortunately, a significant number of people remain reluctant to be vaccinated. In the US, recent poll results showed that 24% of adults said they don’t plan to be vaccinated – and 78% of those people were unlikely to reconsider.

Another report published last month found that even though just 64% of adults in the US said they’d gotten at least one vaccine dose or intended to, general enthusiasm about getting vaccinated was reaching a plateau.

Image: World Economic Forum

For more context, here are links to further reading from the World Economic Forum’s Strategic Intelligence platform:

  • How about a “universal” coronavirus vaccine to prevent the next pandemic? This piece delves into an effort to develop next-generation immunization to protect against known and unknown varieties. (Scientific American)
  • One proven means to overcome vaccine hesitancy in a remote area of India has been to address concerns in Korku, an endangered language still spoken by at least 600,000 indigenous people. (IndiaSpend)
  • People with disabilities haven’t been prioritized for vaccination, according to this opinion piece, even though they account for a disproportionate number of adverse outcomes including a mortality rate in the UK roughly twice that of the general population. (Devex)
  • When a respected medical historian agreed to appear in a documentary about the pandemic, according to this report, she assumed it would be a straightforward piece of journalism – not anti-vaccination propaganda aimed at Black Americans. (Kaiser Health News)
  • Unvaccinated children seem to be reaping the benefits of mass COVID-19 vaccination programmes, but according to this analysis experts disagree on whether these children may now be a potential hotbed for the emergence of new variants. (Nature)
  • Vaccine myth buster: this paper focuses on myths fuelling vaccine hesitancy, and examines the most prevalent related topics including formaldehyde, aluminium, mercury, autism, and misconceptions regarding COVID-19 vaccines. (Frontiers)
  • The global vaccination effort has been nothing short of extraordinary, according to this analysis, but the overwhelming majority of the world’s population remains unprotected. (Project Syndicate)

On the Strategic Intelligence platform, you can find feeds of expert analysis related to Vaccination, COVID-19 and hundreds of additional topics. You’ll need to register to view.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

The Japanese have a word to help them be less wasteful – ‘mottainai’

Commission adopts €70 million package for early access to EU COVID-19 vaccines in the Western Balkans

Who holds the key to the future of biotechnology? You do

UN rights chief bemoans unilateral sanctions on Venezuela, fearing ‘far-reaching implications’

Aid used for trade is helping developing countries diversify

OECD leading multilateral efforts to address tax challenges from digitalisation of the economy

UN rights expert calls for end to ‘purgatory’ of ‘international inaction’ facing Myanmar’s remaining Rohingya

Trump wants to implicate China in US attacks against global order

Is “Sustainable Development” a concept that integrates Health Literacy and Health Policy as a global health action?

With science ‘held back by a gender gap’, Guterres calls for more empowerment for women and girls

Human Rights Council election: 5 things you need to know about it

EU budget: Boosting cooperation between tax and customs authorities for a safer and more prosperous EU

Eurozone plans return to growth

Climate change update: consistent global actions urgently needed as we are running out of time

Fair completion rules and the law of gravity don’t apply to banks

Eurozone very close to a sustainable growth path

FROM THE FIELD: For refugees and migrants in Europe, healthcare’s essential but a challenge to find

Coronavirus: Commission receives first preliminary application for support from the EU Solidarity Fund for health emergency from Italy

On Human Rights Day European Youth Forum calls for end to discrimination of young people

With Gaza violence ‘escalating as we speak,’ UN envoy calls for ‘immediate stop’

Suffering of thousands of war-affected Syrian children ‘unprecedented and unacceptable’

#TwitterisblockedinTurkey and so is Erdogan

Ukraine: €8 million in humanitarian aid to withstand winter

‘Agile’, multilateral response vital to combat terrorism – UN chief Guterres

5 facts you might not know about why forest biodiversity matters

Recovery and Resilience Facility: Belgium, Italy, Austria, and Slovenia submit official recovery and resilience plans

Australia wants to build a giant underground ‘battery’ to help power the nation

Commission proposes to top up support for refugees in Jordan, Lebanon and Turkey

Four things workers want implemented by their bosses post-pandemic

Industrial price dive may lead to point of no return

5 creative alternatives to plastic packaging

FROM THE FIELD: Malawi farmers diversify to fight climate change

The JADE Spring Meeting is about to begin

Boris to end up in jail if he loses the next elections?

6 ways to ensure AI and new tech works for – not against – humanity

Pushing for tax fairness in a digital world

‘Global clarion call’ for youth to shape efforts to forge peace in the most dangerous combat zones

Global health challenges require global medical students

Safer products: EP and Council close deal to beef up checks and inspections

Nagasaki is ‘a global inspiration’ for peace, UN chief says marking 73rd anniversary of atomic bombing

Investing in nature gives industry and business a competitive advantage. Here’s why

CLIMATE CHANGE FOCUS: Climate-proofing Timor-Leste

UNICEF warns of ‘lost generation’ of Rohingya youth, one year after Myanmar exodus

Here’s how we get businesses to harmonize on climate change

EU allocates over €43 million in humanitarian aid to South Sudan

The 5 lessons from New York Climate Week to help us combat deforestation

UN rights office calls on Zimbabwe Government to end ‘crackdown’ in response to fuel protests

1 in 13 young British people have PTSD. Here’s why

The blackened white coat of the doctors

The clothes of the future could be made from pineapples and bananas

COVID-19: Team Europe supports African, Caribbean and Pacific countries to access finance through digital technology

Christine Lagarde: the three priorities for the global economy

“Asia-Pacific takes stock of ambitious development targets”, written by the Heads of UNFPA and ESCAP

Healthcare guidance apps to professional’s continued education?

End fossil fuel subsidies, and stop using taxpayers’ money to destroy the world: Guterres

Youth not prioritised in new Commission

State aid: Commission approves €286 million Finnish measure to recapitalise Finnair

A bad marriage can be as unhealthy as smoking and drinking

Coronavirus Global Response: Commission joins the COVID-19 Vaccine Global Access Facility (COVAX)

Eurozone’s sovereign debt not a problem anymore?

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s